LymphedemaV1, PubMed, Checkpoint, bibRecord, 002595

Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia.

Identifieur interne : 002595 ( PubMed/Checkpoint ); précédent : 002594; suivant : 002596

Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia.

Auteurs : Debidas Ray [Inde] ; S. Harikrishna ; Chandra Immanuel ; Lalitha Victor ; Sudha Subramanyam ; V. Kumaraswami

Source :

The Indian journal of medical research [ 0971-5916 ] ; 2011.

RBID : pubmed:21808138

Descripteurs français

KwdFr :
- Adulte, Allèles, Animaux, Diéthylcarbamazine (usage thérapeutique), Déficit en alpha-1-antitrypsine (génétique), Déficit en alpha-1-antitrypsine (sang), Déficit en alpha-1-antitrypsine (étiologie), Femelle, Filariose lymphatique (épidémiologie), Filarioses (épidémiologie), Humains, Mâle, Poumon éosinophile (), Stress oxydatif, Sujet âgé, Wuchereria bancrofti (isolement et purification), alpha-1-Antitrypsine (génétique), alpha-1-Antitrypsine (sang), Études cas-témoins.
MESH :
- génétique : Déficit en alpha-1-antitrypsine, alpha-1-Antitrypsine.
- isolement et purification : Wuchereria bancrofti.
- sang : Déficit en alpha-1-antitrypsine, alpha-1-Antitrypsine.
- usage thérapeutique : Diéthylcarbamazine.
- épidémiologie : Filariose lymphatique, Filarioses.
- étiologie : Déficit en alpha-1-antitrypsine.
- Adulte, Allèles, Animaux, Femelle, Humains, Mâle, Poumon éosinophile, Stress oxydatif, Sujet âgé, Études cas-témoins.

English descriptors

KwdEn :
- Adult, Aged, Alleles, Animals, Case-Control Studies, Diethylcarbamazine (therapeutic use), Elephantiasis, Filarial (epidemiology), Female, Filariasis (epidemiology), Humans, Male, Oxidative Stress, Pulmonary Eosinophilia (complications), Wuchereria bancrofti (isolation & purification), alpha 1-Antitrypsin (blood), alpha 1-Antitrypsin (genetics), alpha 1-Antitrypsin Deficiency (blood), alpha 1-Antitrypsin Deficiency (etiology), alpha 1-Antitrypsin Deficiency (genetics).
MESH :
- chemical , blood : alpha 1-Antitrypsin.
- chemical , genetics : alpha 1-Antitrypsin.
- chemical , therapeutic use : Diethylcarbamazine.
- blood : alpha 1-Antitrypsin Deficiency.
- complications : Pulmonary Eosinophilia.
- epidemiology : Elephantiasis, Filarial, Filariasis.
- etiology : alpha 1-Antitrypsin Deficiency.
- genetics : alpha 1-Antitrypsin Deficiency.
- isolation & purification : Wuchereria bancrofti.
- Adult, Aged, Alleles, Animals, Case-Control Studies, Female, Humans, Male, Oxidative Stress.

Abstract

Observation of an increased frequency of an intermediate deficiency of serum alpha1-antitrypsin (α1-AT) in patients with Tropical Pulmonary Eosinophilia (TPE) was earlier reported. Though the possibility of existence of an acquired deficiency was suggested, without phenotyping a hereditary α1-AT deficiency in TPE could not totally be ruled out. In this study, we have done Pi (Protease inhibitor) phenotyping to investigate the possibility of association of any heterozygous (or homozygous) α1-AT deficiency in patients with TPE.

PubMed: 21808138

Affiliations:

Inde

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 002503
to stream PubMed, to step Curation: 002503

Links to Exploration step

pubmed:21808138

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia.</title>
<author><name sortKey="Ray, Debidas" sort="Ray, Debidas" uniqKey="Ray D" first="Debidas" last="Ray">Debidas Ray</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Research, Tuberculosis Research Centre (ICMR), Chennai, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Clinical Research, Tuberculosis Research Centre (ICMR), Chennai</wicri:regionArea>
<wicri:noRegion>Chennai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Harikrishna, S" sort="Harikrishna, S" uniqKey="Harikrishna S" first="S" last="Harikrishna">S. Harikrishna</name>
</author>
<author><name sortKey="Immanuel, Chandra" sort="Immanuel, Chandra" uniqKey="Immanuel C" first="Chandra" last="Immanuel">Chandra Immanuel</name>
</author>
<author><name sortKey="Victor, Lalitha" sort="Victor, Lalitha" uniqKey="Victor L" first="Lalitha" last="Victor">Lalitha Victor</name>
</author>
<author><name sortKey="Subramanyam, Sudha" sort="Subramanyam, Sudha" uniqKey="Subramanyam S" first="Sudha" last="Subramanyam">Sudha Subramanyam</name>
</author>
<author><name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21808138</idno>
<idno type="pmid">21808138</idno>
<idno type="wicri:Area/PubMed/Corpus">002503</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002503</idno>
<idno type="wicri:Area/PubMed/Curation">002503</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002503</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002503</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002503</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia.</title>
<author><name sortKey="Ray, Debidas" sort="Ray, Debidas" uniqKey="Ray D" first="Debidas" last="Ray">Debidas Ray</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Research, Tuberculosis Research Centre (ICMR), Chennai, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Clinical Research, Tuberculosis Research Centre (ICMR), Chennai</wicri:regionArea>
<wicri:noRegion>Chennai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Harikrishna, S" sort="Harikrishna, S" uniqKey="Harikrishna S" first="S" last="Harikrishna">S. Harikrishna</name>
</author>
<author><name sortKey="Immanuel, Chandra" sort="Immanuel, Chandra" uniqKey="Immanuel C" first="Chandra" last="Immanuel">Chandra Immanuel</name>
</author>
<author><name sortKey="Victor, Lalitha" sort="Victor, Lalitha" uniqKey="Victor L" first="Lalitha" last="Victor">Lalitha Victor</name>
</author>
<author><name sortKey="Subramanyam, Sudha" sort="Subramanyam, Sudha" uniqKey="Subramanyam S" first="Sudha" last="Subramanyam">Sudha Subramanyam</name>
</author>
<author><name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name>
</author>
</analytic>
<series><title level="j">The Indian journal of medical research</title>
<idno type="ISSN">0971-5916</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Alleles</term>
<term>Animals</term>
<term>Case-Control Studies</term>
<term>Diethylcarbamazine (therapeutic use)</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Female</term>
<term>Filariasis (epidemiology)</term>
<term>Humans</term>
<term>Male</term>
<term>Oxidative Stress</term>
<term>Pulmonary Eosinophilia (complications)</term>
<term>Wuchereria bancrofti (isolation & purification)</term>
<term>alpha 1-Antitrypsin (blood)</term>
<term>alpha 1-Antitrypsin (genetics)</term>
<term>alpha 1-Antitrypsin Deficiency (blood)</term>
<term>alpha 1-Antitrypsin Deficiency (etiology)</term>
<term>alpha 1-Antitrypsin Deficiency (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Allèles</term>
<term>Animaux</term>
<term>Diéthylcarbamazine (usage thérapeutique)</term>
<term>Déficit en alpha-1-antitrypsine (génétique)</term>
<term>Déficit en alpha-1-antitrypsine (sang)</term>
<term>Déficit en alpha-1-antitrypsine (étiologie)</term>
<term>Femelle</term>
<term>Filariose lymphatique (épidémiologie)</term>
<term>Filarioses (épidémiologie)</term>
<term>Humains</term>
<term>Mâle</term>
<term>Poumon éosinophile ()</term>
<term>Stress oxydatif</term>
<term>Sujet âgé</term>
<term>Wuchereria bancrofti (isolement et purification)</term>
<term>alpha-1-Antitrypsine (génétique)</term>
<term>alpha-1-Antitrypsine (sang)</term>
<term>Études cas-témoins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>alpha 1-Antitrypsin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>alpha 1-Antitrypsin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Diethylcarbamazine</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>alpha 1-Antitrypsin Deficiency</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Pulmonary Eosinophilia</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Filariasis</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>alpha 1-Antitrypsin Deficiency</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>alpha 1-Antitrypsin Deficiency</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Déficit en alpha-1-antitrypsine</term>
<term>alpha-1-Antitrypsine</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Déficit en alpha-1-antitrypsine</term>
<term>alpha-1-Antitrypsine</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Diéthylcarbamazine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Filarioses</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Déficit en alpha-1-antitrypsine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Alleles</term>
<term>Animals</term>
<term>Case-Control Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Oxidative Stress</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Allèles</term>
<term>Animaux</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Poumon éosinophile</term>
<term>Stress oxydatif</term>
<term>Sujet âgé</term>
<term>Études cas-témoins</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Observation of an increased frequency of an intermediate deficiency of serum alpha1-antitrypsin (α1-AT) in patients with Tropical Pulmonary Eosinophilia (TPE) was earlier reported. Though the possibility of existence of an acquired deficiency was suggested, without phenotyping a hereditary α1-AT deficiency in TPE could not totally be ruled out. In this study, we have done Pi (Protease inhibitor) phenotyping to investigate the possibility of association of any heterozygous (or homozygous) α1-AT deficiency in patients with TPE.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21808138</PMID>
<DateCreated><Year>2011</Year>
<Month>08</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted><Year>2011</Year>
<Month>12</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0971-5916</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>134</Volume>
<PubDate><Year>2011</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>The Indian journal of medical research</Title>
<ISOAbbreviation>Indian J. Med. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia.</ArticleTitle>
<Pagination><MedlinePgn>79-82</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="BACKGROUND & OBJECTIVES" NlmCategory="OBJECTIVE">Observation of an increased frequency of an intermediate deficiency of serum alpha1-antitrypsin (α1-AT) in patients with Tropical Pulmonary Eosinophilia (TPE) was earlier reported. Though the possibility of existence of an acquired deficiency was suggested, without phenotyping a hereditary α1-AT deficiency in TPE could not totally be ruled out. In this study, we have done Pi (Protease inhibitor) phenotyping to investigate the possibility of association of any heterozygous (or homozygous) α1-AT deficiency in patients with TPE.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Serum a1antitrypsin (α1-AT) was measured in 103 patients (Group A) with TPE, 99 patients with pulmonary eosinophilia who had associated intestinal worm infestation (Group B) and 43 healthy volunteers who served as controls. In 19 α1-AT deficient patients (9 of Group A and 10 of Group B), α1-AT level was measured before and after treatment. In 58 patients with TPE and in 5 controls, phenotyping was done.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifteen patients of Group A and 16 from Group B showed intermediate α1-AT deficiency (150 mg % or less. None of the control subjects had α1-AT deficiency (<200 mg%). After treatment with DEC and/or deworming, in 19 patients there was a significant (P < 0.001) rise in α1-AT levels. Results of phenotyping showed that all had M1 or M 2 allele and none had S or Z variant (either homozygous or heterozygous) thus ruling out any underlying genetic cause for the observed α1-AT deficiency.</AbstractText>
<AbstractText Label="INTERPRETATION & CONCLUSIONS" NlmCategory="CONCLUSIONS">The observed α1-AT deficiency may be due to the chronic inflammation in TPE and associated oxidative stress. However, in such α1-AT deficient patients with TPE and those with worm infested pulmonary eosinophilia, faecal α1-AT concentration and faecal α1-AT clearance should be routinely estimated to rule out the possibility of any intestinal protein loss.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ray</LastName>
<ForeName>Debidas</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Research, Tuberculosis Research Centre (ICMR), Chennai, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Harikrishna</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Immanuel</LastName>
<ForeName>Chandra</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Victor</LastName>
<ForeName>Lalitha</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Subramanyam</LastName>
<ForeName>Sudha</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kumaraswami</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>India</Country>
<MedlineTA>Indian J Med Res</MedlineTA>
<NlmUniqueID>0374701</NlmUniqueID>
<ISSNLinking>0971-5916</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000515">alpha 1-Antitrypsin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber>
<NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Am Rev Respir Dis. 1990 Nov;142(5):1088-92</RefSource>
<PMID Version="1">2173455</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Indian J Clin Biochem. 2008 Oct;23(4):375-7</RefSource>
<PMID Version="1">23105790</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Clin Nutr. 1974 Dec;27(12):1386-9</RefSource>
<PMID Version="1">4139888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2006 Jul;100(7):650-5</RefSource>
<PMID Version="1">16554077</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Pediatr Gastroenterol Nutr. 1990 Feb;10(2):249-52</RefSource>
<PMID Version="1">2303979</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Immunochemistry. 1965 Sep;2(3):235-54</RefSource>
<PMID Version="1">4956917</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Indian J Chest Dis Allied Sci. 2008 Jan-Mar;50(1):49-66</RefSource>
<PMID Version="1">18610690</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Chest. 1993 Aug;104(2):487-92</RefSource>
<PMID Version="1">8339638</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Chest. 2000 May;117(5 Suppl 1):303S-17S</RefSource>
<PMID Version="1">10843965</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lung. 2007 Jul-Aug;185(4):191-201</RefSource>
<PMID Version="1">17562108</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Pediatr Gastroenterol Nutr. 1992 Nov;15(4):404-7</RefSource>
<PMID Version="1">1469520</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1995 Sep-Oct;89(5):573-5</RefSource>
<PMID Version="1">8560543</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Chest. 1996 Dec;110(6 Suppl):267S-272S</RefSource>
<PMID Version="1">8989163</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005368" MajorTopicYN="N">Filariasis</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011657" MajorTopicYN="N">Pulmonary Eosinophilia</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014958" MajorTopicYN="N">Wuchereria bancrofti</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000515" MajorTopicYN="N">alpha 1-Antitrypsin</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019896" MajorTopicYN="N">alpha 1-Antitrypsin Deficiency</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC3171921</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>8</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2011</Year>
<Month>8</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>12</Month>
<Day>13</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">21808138</ArticleId>
<ArticleId IdType="pii">IndianJMedRes_2011_134_1_79_83349</ArticleId>
<ArticleId IdType="pmc">PMC3171921</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Inde</li>
</country>
</list>
<tree><noCountry><name sortKey="Harikrishna, S" sort="Harikrishna, S" uniqKey="Harikrishna S" first="S" last="Harikrishna">S. Harikrishna</name>
<name sortKey="Immanuel, Chandra" sort="Immanuel, Chandra" uniqKey="Immanuel C" first="Chandra" last="Immanuel">Chandra Immanuel</name>
<name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name>
<name sortKey="Subramanyam, Sudha" sort="Subramanyam, Sudha" uniqKey="Subramanyam S" first="Sudha" last="Subramanyam">Sudha Subramanyam</name>
<name sortKey="Victor, Lalitha" sort="Victor, Lalitha" uniqKey="Victor L" first="Lalitha" last="Victor">Lalitha Victor</name>
</noCountry>
<country name="Inde"><noRegion><name sortKey="Ray, Debidas" sort="Ray, Debidas" uniqKey="Ray D" first="Debidas" last="Ray">Debidas Ray</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002595 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002595 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:21808138
   |texte=   Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:21808138" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia.

Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki